Warner Chilcott Nabs Win In Generic Doryx Delay Row
A Pennsylvania federal judge on Thursday tossed Mylan Pharmaceuticals Inc.'s allegations that Warner Chilcott PLC tried to block generic competition for its acne medication Doryx by tweaking its formula, ruling any...To view the full article, register now.
Already a subscriber? Click here to view full article